Viking Therapeutics (VKTX) Earnings Date, Estimates & Call Transcripts $23.72 -0.22 (-0.92%) Closing price 04/21/2025 04:00 PM EasternExtended Trading$24.09 +0.37 (+1.56%) As of 04:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Viking Therapeutics Earnings Summary Upcoming Earnings DateApr. 23After Market ClosesEstimatedConsensus EPS (Feb. 5) -$0.27 Actual EPS (Feb. 5) -$0.32 Missed By -$0.05 Viking Therapeutics posted Q4 2024 earnings on February 5, 2025, reporting an EPS of -$0.32, which missed analysts' consensus estimates of -$0.27 by $0.05. With a trailing EPS of -$1.00, Viking Therapeutics' earnings are expected to decrease next year, from ($1.56) to ($2.07) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Annual Report (10-K) Press Release (8-K)VKTX Upcoming EarningsViking Therapeutics' Q1 2025 earnings is scheduled for Wednesday, April 23, 2025, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportPowered by Get Viking Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Viking Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataVKTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Viking Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20254-$0.35-$0.26-$0.31Q2 20254-$0.41-$0.30-$0.36Q3 20254-$0.47-$0.32-$0.40Q4 20254-$0.50-$0.32-$0.42FY 202516-$1.73-$1.20-$1.48Q1 20261-$0.44-$0.44-$0.44Q2 20261-$0.46-$0.46-$0.46Q3 20261-$0.47-$0.47-$0.47Q4 20261-$0.47-$0.47-$0.47FY 20264($1.84)($1.84)($1.84) Viking Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 4/23/2025(Estimated)-------2/5/2025Q4 2024-$0.27-$0.32 -$0.05-$0.32--10/23/2024Q3 2024-$0.24-$0.22+$0.02-$0.22--7/24/2024Q2 2024-$0.26-$0.20+$0.06-$0.20--4/24/2024Q1 2024-$0.27-$0.26+$0.01-$0.26--2/7/2024Q4 2023-$0.25-$0.25--$0.25--10/25/2023Q3 2023-$0.22-$0.23 -$0.01-$0.23--7/26/2023Q2 2023-$0.21-$0.19+$0.02-$0.19--4/26/2023Q1 2023-$0.24-$0.25 -$0.01-$0.25-- Viking Therapeutics Earnings - Frequently Asked Questions When is Viking Therapeutics's earnings date? Viking Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 23rd, 2025 based off last year's report dates. Learn more on VKTX's earnings history. Did Viking Therapeutics beat their earnings estimates last quarter? In the previous quarter, Viking Therapeutics (NASDAQ:VKTX) missed the analysts' consensus estimate of ($0.27) by $0.05 with a reported earnings per share (EPS) of ($0.32). Learn more on analysts' earnings estimate vs. VKTX's actual earnings. How can I listen to Viking Therapeutics's earnings conference call? The conference call for Viking Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Viking Therapeutics's conference call transcript? The conference call transcript for Viking Therapeutics's latest earnings report can be read online. Read Transcript How much profit does Viking Therapeutics generate each year? Viking Therapeutics (NASDAQ:VKTX) has a recorded net income of -$109.96 million. VKTX has generated -$1.00 earnings per share over the last four quarters. What is Viking Therapeutics's EPS forecast for next year? Viking Therapeutics's earnings are expected to decrease from ($1.56) per share to ($2.07) per share in the next year. More Earnings Resources from MarketBeat Related Companies Moderna Earnings Results Ascendis Pharma A/S Earnings Results Viatris Earnings Results Qiagen Earnings Results Roivant Sciences Earnings Results Revolution Medicines Earnings Results Lantheus Earnings Results BridgeBio Pharma Earnings Results Legend Biotech Earnings Results TG Therapeutics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Archer Aviation Unveils NYC Network Ahead of Key Earnings ReportAlcoa’s Solid Earnings Don’t Make Tariff Math Easier for AA Stock3 Reasons to Like the Look of Amazon Ahead of EarningsTesla Stock Eyes Breakout With Earnings on DeckJohnson & Johnson Earnings Were More Good Than Bad—Time to Buy? Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst Chaos This page (NASDAQ:VKTX) was last updated on 4/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredThey Scared The Nation And Cashed in on ChaosYou weren’t supposed to notice what just happened. While the headlines screamed about tariffs and Trump, Wa...American Hartford Gold | SponsoredBiggest AI gains still ahead…? (Major announcement coming)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viking Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viking Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy vktx Stock Free vktx Stock Alerts